Chemical Structure : CCS1477
CAS No.: 2222941-37-7
货号: PC-38126Not For Human Use, Lab Use Only.
CCS1477 (Inobrodib) is an orally bioavailable, potent, and selective inhibitor of the p300/CBP bromodomain, binds to p300 and CBP with Kds of 1.3 and 1.7 nM respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥1280 | In stock | |
10 mg | ¥1980 | In stock | |
25 mg | ¥3580 | In stock | |
50 mg | ¥5580 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
CCS1477 (Inobrodib) is an orally bioavailable, potent, and selective inhibitor of the p300/CBP bromodomain, binds to p300 and CBP with Kds of 1.3 and 1.7 nM respectively.
CCS1477 (Inobrodib) displays > 170/130-fold selectivity compared with BRD4, CCS1477 binding to cellular histones in an in-cell BRET assay, with an IC50 of 19 nM for p300 and 1060 nM for BRD4.
CCS1477 (Inobrodib) has only minimal binding to BRD2, 3, 4, 9 and WDR9 (14-33% of control at 1 uM) in a bromoscan assay of 32 bromodomains.
CCS1477 inhibits cell proliferation in prostate cancer cell lines and decreases AR- and C-MYC-regulated gene expression.
CCS1477 has antitumor activity, regulating AR and C-MYC signaling in AR-SV-driven models.
CCS1477 modulates KLK3 blood levels and regulates CRPC biopsy biomarker expression.
分子量 | 535.636 | |
分子式 | C31H35F2N3O3 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(3R)-2-(3,4-difluorophenyl)-3-(5-(3,5-dimethyl-4,5-dihydroisoxazol-4-yl)-1-((1r,4R)-4-methoxycyclohexyl)-1H-benzo[d]imidazol-2-yl)cyclohexan-1-one |
1. Jonathan Welti, et al. Cancer Discov. 2021 May;11(5):1118-1137.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright